https://stock.noler.com/us/stock/global-cord-blood-corp https://stock.noler.com/us/stock/global-cord-blood-corp/accounts-payable https://stock.noler.com/us/stock/global-cord-blood-corp/accounts-receivable https://stock.noler.com/us/stock/global-cord-blood-corp/accounts-receivable-billed-for-long-term-contracts-or-programs https://stock.noler.com/us/stock/global-cord-blood-corp/accounts-receivable-gross https://stock.noler.com/us/stock/global-cord-blood-corp/accounts-receivable-gross-current https://stock.noler.com/us/stock/global-cord-blood-corp/accounts-receivable-gross-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/accounts-receivable-net https://stock.noler.com/us/stock/global-cord-blood-corp/accounts-receivable-net-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/accrual-for-taxes-other-than-income-taxes-current https://stock.noler.com/us/stock/global-cord-blood-corp/accrued-income-taxes-current https://stock.noler.com/us/stock/global-cord-blood-corp/accrued-professional-fees-current https://stock.noler.com/us/stock/global-cord-blood-corp/accrued-salaries-current https://stock.noler.com/us/stock/global-cord-blood-corp/accumulated-depreciation https://stock.noler.com/us/stock/global-cord-blood-corp/accumulated-oci-other-than-temporary-impairment-not-credit-loss-net-of-tax-available-for-sale-debt-securities https://stock.noler.com/us/stock/global-cord-blood-corp/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/global-cord-blood-corp/advance-payments-by-borrowers-for-taxes-and-insurance https://stock.noler.com/us/stock/global-cord-blood-corp/advertising-expense https://stock.noler.com/us/stock/global-cord-blood-corp/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/global-cord-blood-corp/allowance-for-doubtful-accounts-receivable-change https://stock.noler.com/us/stock/global-cord-blood-corp/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/global-cord-blood-corp/allowance-for-doubtful-accounts-receivable-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/allowance-for-doubtful-accounts-receivable-write-offs https://stock.noler.com/us/stock/global-cord-blood-corp/amortization https://stock.noler.com/us/stock/global-cord-blood-corp/amortization-of-financing-costs https://stock.noler.com/us/stock/global-cord-blood-corp/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/global-cord-blood-corp/aoci https://stock.noler.com/us/stock/global-cord-blood-corp/available-for-sale-equity-securities https://stock.noler.com/us/stock/global-cord-blood-corp/available-for-sale-equity-securities-amortized-cost-basis https://stock.noler.com/us/stock/global-cord-blood-corp/available-for-sale-equity-securities-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/available-for-sale-gross-realized-gain-loss-excluding-other-than-temporary-impairments https://stock.noler.com/us/stock/global-cord-blood-corp/available-for-sale-unrealized-loss-position-fair-value https://stock.noler.com/us/stock/global-cord-blood-corp/basic-shares https://stock.noler.com/us/stock/global-cord-blood-corp/buyback-authorization https://stock.noler.com/us/stock/global-cord-blood-corp/buybacks-share-repurchases https://stock.noler.com/us/stock/global-cord-blood-corp/buybacks-shares-repurchased https://stock.noler.com/us/stock/global-cord-blood-corp/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/global-cord-blood-corp/buybacks-stock-repurchased-value https://stock.noler.com/us/stock/global-cord-blood-corp/buybacks-treasury-shares-acquired https://stock.noler.com/us/stock/global-cord-blood-corp/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/global-cord-blood-corp/capital-expenditures https://stock.noler.com/us/stock/global-cord-blood-corp/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/global-cord-blood-corp/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/global-cord-blood-corp/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/global-cord-blood-corp/capital-leases-future-minimum-payments-due-in-five-years https://stock.noler.com/us/stock/global-cord-blood-corp/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/global-cord-blood-corp/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/global-cord-blood-corp/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/global-cord-blood-corp/capital-leases-future-minimum-payments-due-thereafter https://stock.noler.com/us/stock/global-cord-blood-corp/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/global-cord-blood-corp/cash-and-equivalents https://stock.noler.com/us/stock/global-cord-blood-corp/cash-and-restricted-cash https://stock.noler.com/us/stock/global-cord-blood-corp/cash-flow-breakdown https://stock.noler.com/us/stock/global-cord-blood-corp/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/global-cord-blood-corp/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/global-cord-blood-corp/common-dividends-paid https://stock.noler.com/us/stock/global-cord-blood-corp/common-stock-dividends-shares https://stock.noler.com/us/stock/global-cord-blood-corp/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/global-cord-blood-corp/common-stock-value https://stock.noler.com/us/stock/global-cord-blood-corp/comprehensive-income https://stock.noler.com/us/stock/global-cord-blood-corp/comprehensive-income-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/global-cord-blood-corp/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/global-cord-blood-corp/contract-liability https://stock.noler.com/us/stock/global-cord-blood-corp/contract-receivable-due-five-years-or-more https://stock.noler.com/us/stock/global-cord-blood-corp/contract-receivable-due-four-to-five-years https://stock.noler.com/us/stock/global-cord-blood-corp/contract-receivable-due-one-to-two-years https://stock.noler.com/us/stock/global-cord-blood-corp/contract-receivable-due-three-to-four-years https://stock.noler.com/us/stock/global-cord-blood-corp/contract-receivable-due-two-to-three-years https://stock.noler.com/us/stock/global-cord-blood-corp/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/contractual-obligation https://stock.noler.com/us/stock/global-cord-blood-corp/convertible-debt-fair-value-disclosures https://stock.noler.com/us/stock/global-cord-blood-corp/convertible-long-term-notes-payable https://stock.noler.com/us/stock/global-cord-blood-corp/convertible-notes-payable https://stock.noler.com/us/stock/global-cord-blood-corp/convertible-notes-payable-current https://stock.noler.com/us/stock/global-cord-blood-corp/cost-method-investments https://stock.noler.com/us/stock/global-cord-blood-corp/cost-of-revenue https://stock.noler.com/us/stock/global-cord-blood-corp/cost-of-services https://stock.noler.com/us/stock/global-cord-blood-corp/cover-page-shares-outstanding https://stock.noler.com/us/stock/global-cord-blood-corp/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/global-cord-blood-corp/current-assets https://stock.noler.com/us/stock/global-cord-blood-corp/current-income-tax-expense-benefit https://stock.noler.com/us/stock/global-cord-blood-corp/current-liabilities https://stock.noler.com/us/stock/global-cord-blood-corp/customer-advances-and-deposits https://stock.noler.com/us/stock/global-cord-blood-corp/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/global-cord-blood-corp/debt-interest-rate-at-period-end https://stock.noler.com/us/stock/global-cord-blood-corp/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/global-cord-blood-corp/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-discounts-finance-charges-and-interest-included-in-receivables https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-finance-costs-current-net https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-income-tax-assets-net https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-income-tax-liabilities https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-offering-costs https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-revenue https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-revenue-2 https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-revenue-change https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-revenue-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-assets-gross-current https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-assets-gross-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-assets-inventory https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-assets-liabilities-net-current https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-assets-liabilities-net-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-assets-net https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-assets-net-current https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-assets-other https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-assets-other-tax-carryforwards https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-liabilities https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-liabilities-current https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-liabilities-deferred-expense https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/global-cord-blood-corp/deferred-tax-liabilities-tax-deferred-income https://stock.noler.com/us/stock/global-cord-blood-corp/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/global-cord-blood-corp/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/global-cord-blood-corp/deposits-assets-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/depreciation https://stock.noler.com/us/stock/global-cord-blood-corp/diluted-shares https://stock.noler.com/us/stock/global-cord-blood-corp/dilutive-shares https://stock.noler.com/us/stock/global-cord-blood-corp/dividends-common-stock https://stock.noler.com/us/stock/global-cord-blood-corp/dividends-paid https://stock.noler.com/us/stock/global-cord-blood-corp/dividends-payable-amount-per-share https://stock.noler.com/us/stock/global-cord-blood-corp/due-from-related-parties-current https://stock.noler.com/us/stock/global-cord-blood-corp/due-to-related-parties-current https://stock.noler.com/us/stock/global-cord-blood-corp/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/global-cord-blood-corp/effect-of-exchange-rate-on-cash-and-cash-equivalents-2 https://stock.noler.com/us/stock/global-cord-blood-corp/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/global-cord-blood-corp/effective-tax-rate https://stock.noler.com/us/stock/global-cord-blood-corp/employee-related-liabilities-current https://stock.noler.com/us/stock/global-cord-blood-corp/eps https://stock.noler.com/us/stock/global-cord-blood-corp/eps-basic https://stock.noler.com/us/stock/global-cord-blood-corp/equity-securities-fv-ni-cost https://stock.noler.com/us/stock/global-cord-blood-corp/equity-securities-fv-ni-gain-loss https://stock.noler.com/us/stock/global-cord-blood-corp/equity-securities-fv-ni-unrealized-loss https://stock.noler.com/us/stock/global-cord-blood-corp/equity-securities-without-readily-determinable-fair-value-amount https://stock.noler.com/us/stock/global-cord-blood-corp/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/global-cord-blood-corp/financing-cash-flow https://stock.noler.com/us/stock/global-cord-blood-corp/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/global-cord-blood-corp/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/global-cord-blood-corp/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/global-cord-blood-corp/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/global-cord-blood-corp/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/global-cord-blood-corp/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/global-cord-blood-corp/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/global-cord-blood-corp/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/global-cord-blood-corp/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/global-cord-blood-corp/foreign-currency-exchange-rate-remeasurement https://stock.noler.com/us/stock/global-cord-blood-corp/foreign-currency-exchange-rate-translation https://stock.noler.com/us/stock/global-cord-blood-corp/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/global-cord-blood-corp/foreign-pretax-income https://stock.noler.com/us/stock/global-cord-blood-corp/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/global-cord-blood-corp/general-and-administrative-expense https://stock.noler.com/us/stock/global-cord-blood-corp/gross-profit https://stock.noler.com/us/stock/global-cord-blood-corp/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/global-cord-blood-corp/income-loss-from-subsidiaries-tax-expense-benefit https://stock.noler.com/us/stock/global-cord-blood-corp/income-tax https://stock.noler.com/us/stock/global-cord-blood-corp/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/global-cord-blood-corp/income-taxes-paid https://stock.noler.com/us/stock/global-cord-blood-corp/income-taxes-paid-2 https://stock.noler.com/us/stock/global-cord-blood-corp/income-taxes-receivable https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-accounts-and-other-receivables https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-deposits-outstanding https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-due-from-related-parties-current https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-inventories https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/global-cord-blood-corp/increase-decrease-in-trading-securities https://stock.noler.com/us/stock/global-cord-blood-corp/insider-transactions-warrants https://stock.noler.com/us/stock/global-cord-blood-corp/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/global-cord-blood-corp/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/global-cord-blood-corp/interest-costs-capitalized https://stock.noler.com/us/stock/global-cord-blood-corp/interest-costs-capitalized-adjustment https://stock.noler.com/us/stock/global-cord-blood-corp/interest-costs-incurred https://stock.noler.com/us/stock/global-cord-blood-corp/interest-expense https://stock.noler.com/us/stock/global-cord-blood-corp/interest-expense-on-debt https://stock.noler.com/us/stock/global-cord-blood-corp/interest-expense-related-party https://stock.noler.com/us/stock/global-cord-blood-corp/interest-on-convertible-debt-net-of-tax https://stock.noler.com/us/stock/global-cord-blood-corp/interest-paid https://stock.noler.com/us/stock/global-cord-blood-corp/interest-paid-net https://stock.noler.com/us/stock/global-cord-blood-corp/interest-payable-current https://stock.noler.com/us/stock/global-cord-blood-corp/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/inventory https://stock.noler.com/us/stock/global-cord-blood-corp/inventory-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/inventory-raw-materials-and-supplies-net-of-reserves https://stock.noler.com/us/stock/global-cord-blood-corp/inventory-valuation-reserves https://stock.noler.com/us/stock/global-cord-blood-corp/investing-cash-flow https://stock.noler.com/us/stock/global-cord-blood-corp/investment-income-dividend https://stock.noler.com/us/stock/global-cord-blood-corp/investment-income-interest https://stock.noler.com/us/stock/global-cord-blood-corp/investment-options-exercise-price https://stock.noler.com/us/stock/global-cord-blood-corp/lease-and-rental-expense https://stock.noler.com/us/stock/global-cord-blood-corp/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/global-cord-blood-corp/liabilities-assumed https://stock.noler.com/us/stock/global-cord-blood-corp/loans-payable-to-bank-current https://stock.noler.com/us/stock/global-cord-blood-corp/long-term-purchase-commitment-amount https://stock.noler.com/us/stock/global-cord-blood-corp/marketable-securities-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/minority-interest https://stock.noler.com/us/stock/global-cord-blood-corp/minority-interest-decrease-from-distributions-to-noncontrolling-interest-holders https://stock.noler.com/us/stock/global-cord-blood-corp/minority-interest-decrease-from-redemptions https://stock.noler.com/us/stock/global-cord-blood-corp/minority-interest-in-net-income-loss-other-minority-interests https://stock.noler.com/us/stock/global-cord-blood-corp/net-cash-from-financing-activities https://stock.noler.com/us/stock/global-cord-blood-corp/net-cash-from-investing-activities https://stock.noler.com/us/stock/global-cord-blood-corp/net-cash-from-operating-activities https://stock.noler.com/us/stock/global-cord-blood-corp/net-change-in-cash https://stock.noler.com/us/stock/global-cord-blood-corp/net-income https://stock.noler.com/us/stock/global-cord-blood-corp/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/global-cord-blood-corp/net-income-loss-attributable-to-redeemable-noncontrolling-interest https://stock.noler.com/us/stock/global-cord-blood-corp/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/global-cord-blood-corp/number-of-operating-segments https://stock.noler.com/us/stock/global-cord-blood-corp/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/global-cord-blood-corp/oci-available-for-sale-tax https://stock.noler.com/us/stock/global-cord-blood-corp/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/global-cord-blood-corp/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/global-cord-blood-corp/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/global-cord-blood-corp/oci-foreign-currency-translation-adjustment-tax https://stock.noler.com/us/stock/global-cord-blood-corp/oci-net-of-tax https://stock.noler.com/us/stock/global-cord-blood-corp/oci-net-of-tax-change https://stock.noler.com/us/stock/global-cord-blood-corp/oci-reclassification-adjustment-from-aoci-for-writedown-of-securities-net-of-tax https://stock.noler.com/us/stock/global-cord-blood-corp/oci-tax https://stock.noler.com/us/stock/global-cord-blood-corp/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/global-cord-blood-corp/operating-cash-flow https://stock.noler.com/us/stock/global-cord-blood-corp/operating-expenses https://stock.noler.com/us/stock/global-cord-blood-corp/operating-income https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-assets https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-expense https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-liability https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-liability-current https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-payments https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-payments-due https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-payments-due-2 https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-payments-due-current https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/global-cord-blood-corp/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/global-cord-blood-corp/other-accrued-liabilities-current https://stock.noler.com/us/stock/global-cord-blood-corp/other-current-assets https://stock.noler.com/us/stock/global-cord-blood-corp/other-income https://stock.noler.com/us/stock/global-cord-blood-corp/other-investments-and-securities-at-cost https://stock.noler.com/us/stock/global-cord-blood-corp/other-long-term-investments https://stock.noler.com/us/stock/global-cord-blood-corp/other-noncurrent-liabilities https://stock.noler.com/us/stock/global-cord-blood-corp/other-nonoperating-income-expense https://stock.noler.com/us/stock/global-cord-blood-corp/other-receivables-net-current https://stock.noler.com/us/stock/global-cord-blood-corp/other-than-temporary-impairment-losses-investments-available-for-sale-securities https://stock.noler.com/us/stock/global-cord-blood-corp/other-than-temporary-impairment-losses-investments-portion-recognized-in-earnings-net-available-for-sale-securities https://stock.noler.com/us/stock/global-cord-blood-corp/paid-in-capital-share-based-compensation-restricted-stock-units-requisite-service-period-recognition https://stock.noler.com/us/stock/global-cord-blood-corp/paid-in-kind-interest https://stock.noler.com/us/stock/global-cord-blood-corp/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/global-cord-blood-corp/payments-for-construction-in-process https://stock.noler.com/us/stock/global-cord-blood-corp/payments-for-other-deposits https://stock.noler.com/us/stock/global-cord-blood-corp/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/global-cord-blood-corp/payments-of-dividends-minority-interest https://stock.noler.com/us/stock/global-cord-blood-corp/payments-to-acquire-available-for-sale-equity https://stock.noler.com/us/stock/global-cord-blood-corp/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/global-cord-blood-corp/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/global-cord-blood-corp/payments-to-acquire-investments https://stock.noler.com/us/stock/global-cord-blood-corp/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/global-cord-blood-corp/payments-to-acquire-other-investments https://stock.noler.com/us/stock/global-cord-blood-corp/payments-to-acquire-other-property-plant-and-equipment https://stock.noler.com/us/stock/global-cord-blood-corp/payments-to-acquire-real-estate https://stock.noler.com/us/stock/global-cord-blood-corp/pledged-assets-not-separately-reported-real-estate https://stock.noler.com/us/stock/global-cord-blood-corp/preferred-shares-facts https://stock.noler.com/us/stock/global-cord-blood-corp/preferred-stock-dividends-and-other-adjustments https://stock.noler.com/us/stock/global-cord-blood-corp/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/global-cord-blood-corp/prepaid-expense-current https://stock.noler.com/us/stock/global-cord-blood-corp/prepaid-expense-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/prepaid-expense-other-noncurrent https://stock.noler.com/us/stock/global-cord-blood-corp/pretax-income https://stock.noler.com/us/stock/global-cord-blood-corp/pretax-income-domestic https://stock.noler.com/us/stock/global-cord-blood-corp/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/global-cord-blood-corp/proceeds-from-bank-debt https://stock.noler.com/us/stock/global-cord-blood-corp/proceeds-from-contributions-from-affiliates https://stock.noler.com/us/stock/global-cord-blood-corp/proceeds-from-convertible-debt https://stock.noler.com/us/stock/global-cord-blood-corp/proceeds-from-income-tax-refunds https://stock.noler.com/us/stock/global-cord-blood-corp/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/global-cord-blood-corp/proceeds-from-minority-shareholders https://stock.noler.com/us/stock/global-cord-blood-corp/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/global-cord-blood-corp/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/global-cord-blood-corp/proceeds-from-sale-of-available-for-sale-equity https://stock.noler.com/us/stock/global-cord-blood-corp/proceeds-from-sale-of-finance-receivables https://stock.noler.com/us/stock/global-cord-blood-corp/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/global-cord-blood-corp/proceeds-from-sale-of-treasury-stock https://stock.noler.com/us/stock/global-cord-blood-corp/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/global-cord-blood-corp/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/global-cord-blood-corp/profit-loss https://stock.noler.com/us/stock/global-cord-blood-corp/property-plant-and-equipment-gross https://stock.noler.com/us/stock/global-cord-blood-corp/property-plant-and-equipment-transfers-and-changes https://stock.noler.com/us/stock/global-cord-blood-corp/property-plant-equipment https://stock.noler.com/us/stock/global-cord-blood-corp/provision-for-doubtful-accounts https://stock.noler.com/us/stock/global-cord-blood-corp/recapitalization-costs https://stock.noler.com/us/stock/global-cord-blood-corp/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/global-cord-blood-corp/related-party-transaction-other-revenues-from-transactions-with-related-party https://stock.noler.com/us/stock/global-cord-blood-corp/repayments-of-bank-debt https://stock.noler.com/us/stock/global-cord-blood-corp/research-and-development https://stock.noler.com/us/stock/global-cord-blood-corp/retained-earnings https://stock.noler.com/us/stock/global-cord-blood-corp/revenue https://stock.noler.com/us/stock/global-cord-blood-corp/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/global-cord-blood-corp/sale-of-stock-consideration-received-per-transaction https://stock.noler.com/us/stock/global-cord-blood-corp/sales-revenue-services-net https://stock.noler.com/us/stock/global-cord-blood-corp/selling-and-marketing-expense https://stock.noler.com/us/stock/global-cord-blood-corp/shareholders-equity https://stock.noler.com/us/stock/global-cord-blood-corp/shares-authorized https://stock.noler.com/us/stock/global-cord-blood-corp/shares-issued https://stock.noler.com/us/stock/global-cord-blood-corp/short-term-bank-loans-and-notes-payable https://stock.noler.com/us/stock/global-cord-blood-corp/significant-acquisitions-and-disposals-acquisition-costs-or-sale-proceeds https://stock.noler.com/us/stock/global-cord-blood-corp/statutory-accounting-practices-statutory-capital-and-surplus-balance https://stock.noler.com/us/stock/global-cord-blood-corp/stock-based-compensation https://stock.noler.com/us/stock/global-cord-blood-corp/stock-issued-new-shares-sold https://stock.noler.com/us/stock/global-cord-blood-corp/stock-issued-shares-issued-shares-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/global-cord-blood-corp/stock-issued-shares-issued-shares-treasury-stock-reissued https://stock.noler.com/us/stock/global-cord-blood-corp/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/global-cord-blood-corp/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/global-cord-blood-corp/stock-issued-shares-issued-value-stock-dividend https://stock.noler.com/us/stock/global-cord-blood-corp/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/global-cord-blood-corp/stock-issued-shares-issued-value-treasury-stock-reissued https://stock.noler.com/us/stock/global-cord-blood-corp/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/global-cord-blood-corp/stockholders-equity-including-portion-attributable-to-noncontrolling-interest-adjusted-balance https://stock.noler.com/us/stock/global-cord-blood-corp/sublease-income https://stock.noler.com/us/stock/global-cord-blood-corp/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/global-cord-blood-corp/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/global-cord-blood-corp/tax-reconciliation-deductions https://stock.noler.com/us/stock/global-cord-blood-corp/tax-reconciliation-deductions-extraterritorial-income-exclusion https://stock.noler.com/us/stock/global-cord-blood-corp/tax-reconciliation-deductions-other https://stock.noler.com/us/stock/global-cord-blood-corp/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/global-cord-blood-corp/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/global-cord-blood-corp/tax-reconciliation-tax-exempt-income https://stock.noler.com/us/stock/global-cord-blood-corp/taxes-payable-current https://stock.noler.com/us/stock/global-cord-blood-corp/temporary-equity-accretion-to-redemption-value https://stock.noler.com/us/stock/global-cord-blood-corp/total-assets https://stock.noler.com/us/stock/global-cord-blood-corp/total-contract-liability https://stock.noler.com/us/stock/global-cord-blood-corp/total-liabilities https://stock.noler.com/us/stock/global-cord-blood-corp/total-liabilities-and-equity https://stock.noler.com/us/stock/global-cord-blood-corp/total-long-term-debt https://stock.noler.com/us/stock/global-cord-blood-corp/trading-securities https://stock.noler.com/us/stock/global-cord-blood-corp/trading-securities-current https://stock.noler.com/us/stock/global-cord-blood-corp/trading-securities-realized-gain-loss https://stock.noler.com/us/stock/global-cord-blood-corp/trading-securities-unrealized-holding-gain-loss https://stock.noler.com/us/stock/global-cord-blood-corp/treasury-stock-common-shares https://stock.noler.com/us/stock/global-cord-blood-corp/treasury-stock-common-value https://stock.noler.com/us/stock/global-cord-blood-corp/treasury-stock-shares https://stock.noler.com/us/stock/global-cord-blood-corp/treasury-stock-value https://stock.noler.com/us/stock/global-cord-blood-corp/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/global-cord-blood-corp/undistributed-earnings-loss-allocated-to-participating-securities-basic https://stock.noler.com/us/stock/global-cord-blood-corp/undistributed-earnings-of-domestic-subsidiaries https://stock.noler.com/us/stock/global-cord-blood-corp/unrecognized-deferred-tax-liability-undistributed-earnings-of-domestic-subsidiaries https://stock.noler.com/us/stock/global-cord-blood-corp/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/global-cord-blood-corp/value-added-tax-receivable-current https://stock.noler.com/us/stock/global-cord-blood-corp/variable-lease-cost https://stock.noler.com/us/stock/global-cord-blood-corp/weighted-average-number-of-share-outstanding-basic-and-diluted